400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2024-01-23
基因疗法研发商
医药研发/制造
化学&生物药
KIMCO;
KIMCO;
Dong-A ST;
Dong-A ST;
K2 Investment Partners;
Terra VC;
LoftyRock Investment;
Pathway Partners;
ACVC;
Mirae Asset Venture Investments;
KDB Silicon Valley;
Timefolio Asset Management;
IMM Investment;
KB Investment;
Dayli Partners;
Woori Venture Partners;
Korea Investment Partners;
Sequoia Capital;
Eli Lilly
2023-10-17
可穿戴医疗设备开发商
医疗器械
诊断/监护器械
2022-02-11
互联网医疗平台
健康管理
心理咨询
Samsung NEXT;
Samsung NEXT;
Green Cross;
Green Cross;
E& Investment;
Insight Equity Partners;
K2 Investment Partners;
Hashed
2020-08-25
基于外泌体的美学产品研发、生产商
医药研发/制造
化学&生物药
K2 Investment Partners;
K2 Investment Partners;
Dt&Investment;
Dt&Investment;
Focus Assets Management;
G.N. Tech
2020-01-06
数字治疗服务提供商
医疗器械
医疗器械软件
Company K Partners;
Company K Partners;
K2 Investment Partners;
K2 Investment Partners;
KTB Network
2018-09-12
基于外泌体的美学产品研发、生产商
医药研发/制造
化学&生物药
Seven Tree Equity Partners;
Seven Tree Equity Partners;
CSQUARED Global Asset Management;
CSQUARED Global Asset Management;
Atinum Investment;
KDB Capital;
TS Investment;
K2 Investment Partners;
InterVest;
Quantum Venture Partners;
GU Equity Partners
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10